Emergent BioSolutions (EBS) Tops Q1 EPS by 22c
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $7.95 +1.27%
EPS Growth %: -31.3%
Financial Fact:
Other income (expense), net: -234K
Today's EPS Names:
MAYS, CRMT, REPL, More
EPS Growth %: -31.3%
Financial Fact:
Other income (expense), net: -234K
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Emergent BioSolutions (NYSE: EBS) reported Q1 EPS of $0.71, $0.22 better than the analyst estimate of $0.49. Revenue for the quarter came in at $222.2 million versus the consensus estimate of $279 million.
For earnings history and earnings-related data on Emergent BioSolutions (EBS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart to pay $1.4 billion for Vibe.co acquisition - WSJ
- William Blair Upgrades Backblaze Inc (BLZE) to Market Perform
- SentinelOne, Inc. (S) call put ratio 3.9 calls to 1 put with a focus on July 15 and 16 calls as share price up 3.4%
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
